Groundbreaking research have a potential of ABX-IL8, the novel compound designed to selectively target interleukin-8 (IL-8), a crucial inflammatory mediator implicated in several pathological diseases . Unlike non-specific approaches , ABX-IL8 offers this targeted action to reduce IL-8 activity , possibly leading to better outcomes in diseases suc